Seroprevalence of hepatitis E among iranian renal transplant recipients

Hepatitis Monthly

Volumn 11, Issue 8, 2011, Pages 646-651

  Khameneh, Zakieh Rostamzadeh ^a   Sepehrvand, Nariman ^a   Masudi, Sima ^b  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti HEV IgG; ELISA; Hepatitis E; Renal transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; HEPATITIS E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGE; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; BLOOD TRANSFUSION; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT RECIPIENT; HEMODIALYSIS; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IRAN; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; SEROLOGY; SEROPREVALENCE;

EID: 80052571278     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/kowsar.1735143X.690     Document Type: Article

References (36)

1. Buti M, Cabrera C, Jardi R, Castells L, Esteban R. Are recipients of solid organ transplantation a high-risk population for hepatitis E virus infection? Liver Transpl. 2010;16(1):106-107; author reply 8.
2. Hosseini-Moghaddam SM, Zarei A, Alavian SM, Mansouri M. Hepatitis E virus infection: a general review with a focus on hemodialysis and kidney transplant patients. Am J Nephrol. 2010;31(5):398-407.
3. Meng XJ. Recent advances in Hepatitis E virus. J Viral Hepat. 2010;17(3):153-161.
4. Taremi M, Khoshbaten M, Gachkar L, EhsaniArdakani M, Zali M. Hepatitis E virus infection in hemodialysis patients: a seroepidemiological survey in Iran. BMC Infect Dis. 2005;5(1):36.
5. Kamar N, Selves J, Mansuy JM, Ouezzani L, Péron JM, Guitard J, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008;358(8):811-817.
6. Aggarwal R, Naik S. Epidemiology of hepatitis E: current status. J Gastroenterol Hepatol. 2009;24(9):1484-1493.
7. Ariyegan M, Amini S. Hepatitis E epidemic in IRAN. J Med Council IRIrn. 1998;15:139-143.
8. Assarehzadegan MA, Shakerinejad G, Amini A, Rezaee SA. Seroprevalence of hepatitis E virus in blood donors in Khuzestan Province, southwest Iran. Int J Infect Dis. 2008;12(4):387-390.
9. Ataei B, Nokhodian Z, Javadi AA, Kassaian N, Shoaei P, Farajzadegan Z, et al. Hepatitis E virus in Isfahan Province: a population-based study. Int J Infect Dis. 2009;13(1):67-71.
10. Saffar MJ, Farhadi R, Ajami A, Khalilian AR, Babamahmodi F, Saffar H. Seroepidemiology of hepatitis E virus infection in 2-25-yearolds in Sari district, Islamic Republic of Iran. East Mediterr Health J. 2009;15(1):136-142.
11. Taremi M, Gachkar L, MahmoudArabi S, Kheradpezhouh M, Khoshbaten M. Prevalence of antibodies to hepatitis E virus among male blood donors in Tabriz, Islamic Republic of Iran. East Mediterr Health J. 2007;13(1):98-102.
12. Taremi M, Mohammad Alizadeh AH, Ardalan A, Ansari S, Zali MR. Seroprevalence of hepatitis E in Nahavand, Islamic Republic of Iran: a population-based study. East Mediterr Health J. 2008;14(1):157-162.
13. Aggarwal R. Hepatitis E: does it cause chronic hepatitis? Hepatology. 2008;48(4):1328-1330.
14. Khuroo MS, Kamili S, Yattoo GN. Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J Gastroenterol Hepatol. 2004;19(7):778-784.
15. Matsubayashi K, Nagaoka Y, Sakata H, Sato S, Fukai K, Kato T, et al. Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion. 2004;44(6):934-940.
16. Mitsui T, Tsukamoto Y, Yamazaki C, Masuko K, Tsuda F, Takahashi M, et al. Prevalence of hepatitis E virus infection among hemodialysis patients in Japan: evidence for infection with a genotype 3 HEV by blood transfusion. J Med Virol. 2004;74(4):563-572.
17. Kamar N, Mansuy JM, Cointault O, Selves J, Abravanel F, Danjoux M, et al. Hepatitis E virus-related cirrhosis in kidney-and kidney-pancreas-transplant recipients. Am J Transplant. 2008;8(8):1744-1748.
18. Gérolami R, Moal V, Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med. 2008;358(8):859-860.
19. Gérolami R, Moal V, Picard C, Colson P. Hepatitis E virus as an emerging cause of chronic liver disease in organ transplant recipients. J Hepatol. 2009;50(3):622-624.
20. Buffet C, Laurent-Puig P, Chandot S, Laurian Y, Charpentier B, Briantais MJ, et al. A high hepatitis E virus seroprevalence among renal transplantation and haemophilia patient populations. J Hepatol. 1996;24(1):122-125.
21. Ibarra H, Riedemann S, Reinhardt G, Ardiles L, Calvo M, Siegel F. Anti-HEV in dialysis and renal transplant patients in an endemic region in Chile. Clin Nephrol. 1998;50(4):267-268.
22. Khameneh ZR, Sepehrvand N, Masudi S, Taghizade-Afshari A. Seroprevalence of HTLV-1 among kidney graft recipients: a single-center study. Exp Clin Transplant. 2010;8(2):146-149.
23. Kamar N, Mansuy JM, Esposito L, Legrand-Abravanel F, Peron JM, Durand D, et al. Acute hepatitis and renal function impairment related to infection by hepatitis E virus in a renal allograft recipient. Am J Kidney Dis. 2005;45(1):193-196.
24. Verhoeven Y, Bac DJ, Feith GW. Liver cirrhosis due to hepatitis E in a kidney transplant patient. Ned Tijdschr Geneeskd. 2010;154(25):A1790.
25. Tamura A, Shimizu YK, Tanaka T, Kuroda K, Arakawa Y, Takahashi K, et al. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol Res. 2007;37(2):113-120.
26. Mansuy JM, Legrand-Abravanel F, Calot JP, Peron JM, Alric L, Agudo S, et al. High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France. J Med Virol. 2008;80(2):289-293.
27. Montella F, Rezza G, Di Sora F, Pezzotti P, Recchia O. Association between hepatitis E virus and HIV infection in homosexual men. Lancet. 1994;344(8934):1433.
28. Kamar N, Rostaing L, Selves J, Sandres-Saune K, Alric L, Durand D, et al. Natural history of hepatitis C virus-related liver fibrosis after renal transplantation. Am J Transplant. 2005;5(7):1704-12.
29. Arankalle VA, Chobe LP. Retrospective analysis of blood transfusion recipients: evidence for post-transfusion hepatitis E. Vox Sang. 2000;79(2):72-4.
30. Ramalho HJ, Terra EG, Cartapatti E, Barberato JB, Alves VA, Gayotto LC, et al. Hepatotoxicity of azathioprine in renal transplant recipients. Transplant Proc. 1989;21(1 Pt 2):1716-7.
31. Jacques J, Dickson Z, Carrier P, Essig M, Guillaudeau A, Lacour C, et al. Severe sirolimus-induced acute hepatitis in a renal transplant recipient. Transpl Int. 2010;23(9):967-970.
32. Chen CH, Huang MH, Yang JC, Nien CK, Yang CC, Yeh YH, et al. Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan. J Gastroenterol Hepatol. 2007;22(9):1482-1489.
33. Pendino GM, Mariano A, Surace P, Caserta CA, Fiorillo MT, Amante A, et al. Prevalence and etiology of altered liver tests: a populationbased survey in a Mediterranean town. Hepatology. 2005;41(5):1151-1159.
34. Mathur P, Arora NK, Panda SK, Kapoor SK, Jailkhani BL, Irshad M. Sero-epidemiology of hepatitis E virus (HEV) in urban and rural children of North India. Indian Pediatr. 2001;38(5):461-475.
35. Oncu S, Oncu S, Okyay P, Ertug S, Sakarya S. Prevalence and risk factors for HEV infection in pregnant women. Med Sci Monit. 2006;12(1):36-39.
36. Pisanti FA, Coppola A, Galli C. Association between hepatitis C and hepatitis E viruses in southern Italy. Lancet. 1994;344(8924):746-747.